Sector: Healthcare
X4 Pharmaceuticals is a biopharmaceutical company focused on developing small-molecule therapies for rare diseases and immune system disorders, including treatments targeting CXCR4 signaling.
We are tracking 1 layoff event for X4 Pharmaceuticals as of Sep 23, 2025.
X4 is laying off 50% of its workforce to save $13 million annually, including its COO, CCO, and CLCO.
Healthcare
French biopharmaceutical firm Valneva is cutting up to 15% of its global workforce, impacting over 100 employees, following a significant revenue drop and
May 18, 2026
Read storyHealthcare
Takeda is implementing a global "transformation program" to streamline operations and cut costs, resulting in 4,500 job reductions worldwide.
May 14, 2026
Read storyHealthcare
INTEGRIS Health in Oklahoma confirms upcoming workforce reductions and clinic closures due to anticipated Medicaid and Medicare funding cuts.
Apr 17, 2026
Read storyHealthcare
Greenwood Leflore Hospital in Mississippi issued a WARN notice, warning employees of potential layoffs as the hospital prepares to close on June 15.
Apr 14, 2026
Read story